Associate Professor, Pathology, University of Pittsburgh School of Medicine
Pathology
Dr. Sanja Dacic, MD
|
|
Give Review
Sanja Dacic, MD works in the field of Pathology. Sanja Dacic has written publications. She has 99 publications published with PubMed. The lastest publication is: 'Pentagastrin cytoprotection in ethanol-induced gastric mucosal lesions in rats.' She accepts all Medicare patients.
Publications
- The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma.
- Cytopathology of pulmonary adenocarcinoma with a single histological pattern using the proposed International Association for the Study of Lung Cancer/American Thoraci...
- Reproducibility of Histopathological Diagnosis in Poorly Differentiated NSCLC: An International Multiobserver Study.
- Reply to verification bias in diagnostic accuracy studies for fine-needle aspiration cytology.
- Correlation of Cytomorphology and Molecular Findings in EGFR+, KRAS+, and ALK+ Lung Carcinomas.
- RET Rearrangements in Lung Adenocarcinoma and Radiation.
- Evaluation of endobronchial ultrasound-guided fine-needle aspirations (EBUS-FNA): Correlation with Adequacy and Histologic follow-up.
- HepPar-1 Expression in Primary Lung Adenocarcinoma.
- Cytologic subtyping of lung adenocarcinoma by using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory ...
- Malignancies incidentally detected at lung transplantation: radiologic and pathologic features.
- KRAS mutational analysis and immunohistochemical studies can help distinguish pancreatic metastases from primary lung adenocarcinomas.
- Pulmonary Langerhans cell histiocytosis: profiling of multifocal tumors using next-generation sequencing identifies concordant occurrence of BRAF V600E mutations.
- p16 Deletion in Sarcomatoid Tumors of the Lung and Pleura.
- Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group.
- Clear Cell Odontogenic Carcinomas Show EWSR1 Rearrangements: A Novel Finding and a Biological Link to Salivary Clear Cell Carcinomas.
- Genetic variation in ESR2 and estrogen receptor-beta expression in lung tumors.
- Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, Int...
- The prognostic and predictive value of KRAS oncogene substitutions in lung adenocarcinoma.
- Sex-determining region Y-box 2 amplification in preneoplastic squamous lesions of the lung.
- Morphologic and clinicopathologic features of lung squamous cell carcinomas expressing Sox2.
- Dilemmas in lung cancer staging.
- Prospective testing of mucoepidermoid carcinoma for the MAML2 translocation: Clinical Implications.
- Bronchoscopic and transthoracic cytology and biopsy for pulmonary nonsmall cell carcinomas: Performance characteristics by procedure and tumor type.
- A Multiplexed Serum Biomarker Immunoassay Panel Discriminates Clinical Lung Cancer Patients from High-Risk Individuals Found to be Cancer-Free by CT Screening.
- Genotypic analysis of pulmonary Langerhans cell histiocytosis.
- Altered p53 in microdissected, metachronous, premalignant and malignant oral lesions from the same patients.
- Col1a1-driven transgenic markers of osteoblast lineage progression.
- Postoperative fluorescence bronchoscopic surveillance in non-small cell lung cancer patients.
- Nodular amyloidoma and primary pulmonary lymphoma with amyloid production: a differential diagnostic problem.
- Fluorescence bronchoscopic surveillance after curative surgical resection for non-small-cell lung cancer.
- Ectopic Msx2 overexpression inhibits and Msx2 antisense stimulates calvarial osteoblast differentiation.
- Pentagastrin cytoprotection in ethanol-induced gastric mucosal lesions in rats.
- Overexpression of p53 protein is common in premalignant head and neck lesions.
- Fluorescence bronchoscopic surveillance in patients with a history of non-small cell lung cancer.
- Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas.
- Gross cystic disease fluid protein-(GCDFP-15): expression in primary lung adenocarcinoma.
- Array comparative genomic hybridization analysis of solid pseudopapillary neoplasms of the pancreas.
- Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer.
- Therapeutic effects of combined treatment with ribavirin and tiazofurin on experimental autoimmune encephalomyelitis development: clinical and histopathological evalua...
- Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation.
- Immunohistological determination of ecto-nucleoside triphosphate diphosphohydrolase1 (NTPDase1) and 5'-nucleotidase in rat hippocampus reveals overlapping distribution.
- Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
- Overexpression of Dicer in precursor lesions of lung adenocarcinoma.
- Microsatellite instability is uncommon in lymphoepithelioma-like carcinoma of the lung.
- Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis.
- 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
- Significance of EGFR protein expression and gene amplification in non-small cell lung carcinoma.
- Transgenic mice overexpressing hepatocyte growth factor in the airways show increased susceptibility to lung cancer.
- Patterns of allelic loss of synchronous adenocarcinomas of the lung.
- Persistent fever in a lung transplant patient.
- Clonal selection of adenocarcinoma of the lung as determined by loss of heterozygosity.
- Significance of a solitary perivascular mononuclear infiltrate in lung allograft recipients with mild acute cellular rejection.
- Protein expression and gene amplification of epidermal growth factor receptor in thymomas.
- Pulmonary lymphohistiocytic reactions temporally related to etanercept therapy.
- Loss of heterozygosity patterns of sclerosing hemangioma of the lung and bronchioloalveolar carcinoma indicate a similar molecular pathogenesis.
- Histologic classification of idiopathic chronic interstitial pneumonias.
- Widespread molecular alterations present in stage I non-small cell lung carcinoma fail to predict tumor recurrence.
- Idiopathic bronchiolocentric interstitial pneumonia.
- Immunohistochemical profile of cystosarcoma phyllodes of the breast: a study of 23 cases.
- Small-cell neuroendocrine carcinoma displays unique profiles of tumor-suppressor gene loss in relationship to the primary site of formation.
- Encapsulated follicular variant of papillary thyroid carcinoma.
- Molecular pathogenesis of pulmonary carcinosarcoma as determined by microdissection-based allelotyping.
- Serum biomarker profiles as diagnostic tools in lung cancer.
- The importance of 10q status in an outcomes-based comparison between 1p/19q fluorescence in situ hybridization and polymerase chain reaction-based microsatellite loss ...
- Lung carcinoma morphology or mutational profile: that is the question.
- EGFR expression stratifies oligodendroglioma behavior.
- Genomic pathology: challenges for implementation.
- Fluorescence in situ hybridization for detection of MAML2 rearrangements in oncocytic mucoepidermoid carcinomas: utility as a diagnostic test.
- KRAS mutant allele-specific imbalance in lung adenocarcinoma.
- Usefulness of immunohistochemical and histochemical studies in the classification of lung adenocarcinoma and squamous cell carcinoma in cytologic specimens.
- Molecular diagnostics of lung carcinomas.
- An update in molecular diagnostics of solid tumors.
- Adenosquamous carcinoma of the lung: a microdissection study of KRAS and EGFR mutational and amplification status in a western patient population.
- The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations.
- The HLA class II Allele DRB1*1501 is over-represented in patients with idiopathic pulmonary fibrosis.
- Lung cancer and the future of pathology.
- Dynamic changes in the expression pattern of ecto-5'-nucleotidase in the rat model of cortical stab injury.
- Progressive genetic alterations of adenoid cystic carcinoma with high-grade transformation.
- Revolution in lung cancer: new challenges for the surgical pathologist.
- Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced...
- Combined analysis of estrogen receptor beta-1 and progesterone receptor expression identifies lung cancer patients with poor outcome.
- Phase II study of everolimus (RAD001) in previously treated small cell lung cancer.
- miRNA expression profiling of lung adenocarcinomas: correlation with mutational status.
- The prognostic value of Ki-67, p53, epidermal growth factor receptor, 1p36, 9p21, 10q23, and 17p13 in skull base chordomas.
- A reappraisal of the MECT1/MAML2 translocation in salivary mucoepidermoid carcinomas.
- Expression analysis of Ubc9, the single small ubiquitin-like modifier (SUMO) E2 conjugating enzyme, in normal and malignant tissues.
- Molecular testing in lung carcinoma: Quo vadis?
- Fine needle aspiration biopsy diagnosis of dedifferentiated liposarcoma: Cytomorphology and MDM2 amplification by FISH.
- EGFR fluorescence in situ hybridization-positive lung adenocarcinoma: incidence of coexisting KRAS and BRAF mutations.
- CDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16 protein expression and poor survival.
- Subdividing NSCLC: reflections on the past, present, and future of lung cancer therapy.
- Ribavirin administration alters ectonucleotidase activities in experimental autoimmune encephalomyelitis.
- Regional changes in ectonucleotidase activity after cortical stab injury in rat.
- Clinicopathological predictors of EGFR/KRAS mutational status in primary lung adenocarcinomas.
- A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases.
- Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.
- Minimally invasive adenocarcinomas of the lung.
- Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma.
Doctors Specialties
- Anatomic Pathology
- Pathology
Accepted Insurances
Education
-
University of Pittsburgh Medical Center -
University of Zagreb Faculty of Medicine
Hospital
-
UPMC Passavant -
UPMC Presbyterian Shadyside
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1497727002 |
| Last Name Of The Provider | DACIC |
| First Name Of The Provider | SANJA |
| View All |
Similar Doctors
|
|
Dr. Michael J. Becich, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey L. Fine, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Miroslawa W. Jones, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sara E. Monaco, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonhan Ho, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Blima K. Mitre, MD |
|
|
Dr. Shih-Fan Kuan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James M. Primavera, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mahpareh G. Mostoufizadeh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael A. Nalesnik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer L. Picarsic, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eizaburo Sasatomi, MD |
|
|
Dr. Edward F. Lynch Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan A. Silver, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel A. Yousem, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert J. Hartsock, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ryan A. Collins, MD |
|
|
Dr. Gutti R. Rao, MD |
|
|
Dr. Rebecca Z. Ocque, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark H. Yazer, MD
This Doctor is OpenDoctor Recommended.
|